Zydus Claims Exclusivities After A Pair Of US Approvals

Gets Nod For First Generic Ibrutinib Capsules And Macitentan Tablets

 
• By David Wallace
  
Exclusive Metal Letters
Zydus Cadila has claimed exclusivity eligibility for two US generics • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin